Navigation Links
Inhaled betadine leads to rare complication
Date:2/21/2013

Philadelphia, Pa. (February 21, 2013) - A routine step in preparing for cleft palate surgery in a child led to an unusualbut not unprecedentedcase of lung inflammation (pneumonitis), according to a report in the The Journal of Craniofacial Surgery. The journal, edited by Mutaz B. Habal, MD, FRCSC, is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

The complication resulted from accidental inhalation of povidone-iodine (PI), or Betadinean antiseptic widely used before surgery. The rare complication led to new surgical "prep" steps to reduce the chances of inhaling PI during head and neck surgery, write Drs. Kyle J. Chepla and Arun K. Gosain of University HospitalsCase Medical Center, Cleveland.

Betadine Inhlation Leads to Chemical Pneumonitis

Drs. Chepla and Gosain describe their experience with Betadine-induced pneumonitis in a seven-year-old girl undergoing surgery for a persistent cleft palate deformity. After a breathing tube was placed and anesthesia was induced, the patient underwent routine surgical prepincluding scrubbing and rinsing the nose and mouth with Betadine.

Betadine is the familiar antiseptic, orange or yellow in color, used before many types of medical and surgical procedures. In the case report, Dr. Kepla writes that he has routinely used Betadine for prep before craniofacial surgery for more than 20 years with no complications.

But in this case, shortly after rinsing the inside of the nose, the surgeons noted Betadine in the patient's breathing tube. She rapidly developed difficulty breathing, with a drop in blood oxygen levels.

The procedure was stopped and the patient was rushed to the ICU for treatment. Although the child eventually recovered completely, she required seven days of mechanical ventilation.

This patient's condition was diagnosed as chemical pneumonitisinflammation of the lungs caused by inhalation of some type of irritant. Pneumonitis most commonly results from inhalation (aspiration) of the stomach contents.

Because it is effective against a wide range of bacteria, viruses, and other pathogens, Betadine is one of the most commonly used disinfectants. It is useful in preparing for surgical procedures of the head and neck, because it does not irritate the mucosal lining. However, studies in animals have shown that Betadine can cause inflammatory damage to the lungs, if inhaled.

Prompted by their experience, Drs. Chepla and Gosain performed a comprehensive review of the medical literature to look for similar cases. The review identified three previous cases of chemical pneumonitis caused by Betadine after disinfection of the mouth. All patients recovered after a period of mechanical ventilation.

Although Betadine-induced pneumonitis appears very rare, Drs. Chepla and Gosain have modified their routines to reduce the risk of this complication. They write, "We conclude that PI is safe to use as a disinfectant before head and neck surgery, but surgeons need to be aware of the risk for PI aspiration and take the appropriate steps to prevent its passage into the tracheobronchial tree."


'/>"/>

Contact: Connie Hughes
connie.hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health
Source:Eurekalert

Related medicine news :

1. Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study
2. Study evaluates use of inhaled saline for young children with cystic fibrosis
3. Epilepsy Leads to More Brain Abnormalities Over Time
4. How a cancer drug leads to diabetes
5. Georgetown physician leads national resveratrol study for Alzheimers disease
6. Study finds Massachusetts health reform leads to increased inpatient surgical procedures
7. Rutgers leads effort to replicate care management programs in 4 U.S. cities
8. Fun in the Kitchen and Eating 300 Calorie Meals Leads to Weight Loss for Fat Guy
9. AIUM and AUA guideline development leads to practice accreditation for urologic ultrasound
10. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
11. Protein build-up leads to neurons misfiring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... An essential tool for ... and certain Canadian provinces is now available from the International Association of Industrial ... , The report, Workers’ Compensation Laws as of January 1, 2016, ...
(Date:5/5/2016)... ... 05, 2016 , ... Tim Dieter has announced the latest ... Dubuque, IA. The current campaign fundraises for Veteran’s Freedom Center on behalf of ... Freedom Center may now be made here: http://www.veteransfreedomcenter.com/donate/ . , Veteran’s Freedom ...
(Date:5/5/2016)... ... ... Dr. Benjamin Stong of Kalos Facial Plastic Surgery, LLC in Atlanta, Georgia proudly ... certified and the only facial plastic surgeon in Atlanta to offer Micro-droplet Fat ... stem cells can be used to provide stabilization to hair transplant results or they ...
(Date:5/5/2016)... York) , ... (PRWEB) May 05, 2016 , ... ... talent acquisition startup, HireNurses, on the eve of National Nurses Week (May ... nurses and healthcare employers. With their enrollment into the Talent Tech Lab Virtual Incubation ...
(Date:5/5/2016)... Rochester, NY (PRWEB) , ... May 05, 2016 ... ... app is now available for iOS and Android devices. VisualDx is the ... expanded to include diagnostic support across general medicine. The system speeds diagnosis, ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Research and ... Systemic Lupus Erythematosus Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Systemic Lupus Erythematosus Market and Competitive Landscape ... Systemic Lupus Erythematosus pipeline products, Systemic Lupus ...
(Date:5/4/2016)... Israel , May 4, 2016 ... that BiondVax,s CEO, Dr. Ron Babecoff , will be ... New York City . On Thursday, May ... 2016, a conference presented by Joseph Gunner & ... The BiondVax presentation that Dr. Babecoff will be using ...
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
Breaking Medicine Technology: